Brief: Rovi Expects Risperidone To Reach Potential Sales Of 100-200 Mln Euros Globally Over Next Few Years
06/05/2026 07:33
May 6 (Reuters) - Laboratorios Farmaceuticos ROVI SA ROVI.MC: SEES ITS CDMO BUSINESS SALES TO DOUBLE BY 2030, REACHING AROUND 700 MILLION EUROS, WITH AN ESTIMATED CAPACITY UTILISATION RATIO OF BETWEEN 70% AND 75% SEES RISPERIDONE WILL REACH POTENTIAL SALES OF BETWEEN 100 AND 200 MILLION EUROS GLOBALLY OVER NEXT FEW YEARS Source text: ID:nCNM3WtM7C Further company coverage: ROVI.MC (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))